Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications
Mateusz Dróżdż, Sebastian Makuch, Gabriela Cieniuch, et al.
Life Sciences (2020) Vol. 261, pp. 118296-118296
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 67
Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
Haojie Chen, Pengyu Lei, Hao Ji, et al.
Materials Today Bio (2023) Vol. 18, pp. 100543-100543
Open Access | Times Cited: 58
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance
Ting‐Wan Kao, Geng-Hao Bai, Tian‐Li Wang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 46
Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy
Kajal Gupta, Christina Nowicki, Eileena F. Giurini, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1497-1497
Open Access | Times Cited: 73
Programming the lifestyles of engineered bacteria for cancer therapy
Shengwei Fu, Rongrong Zhang, Yanmei Gao, et al.
National Science Review (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 30
Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy
Yaofeng Zhou, Qianying Li, Yuhao Wu, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 15
Genetically Engineered Bacteria as a Promising Therapeutic Strategy Against Cancer: A Comprehensive Review
Zahra Zahedifard, Shirin Mahmoodi, Abdolmajid Ghasemian
Biotechnology and Applied Biochemistry (2025)
Closed Access | Times Cited: 1
A global bibliometric and visualized analysis of bacteria-mediated cancer therapy
Jiawei Wang, Mohammed Maniruzzaman
Drug Discovery Today (2022) Vol. 27, Iss. 10, pp. 103297-103297
Open Access | Times Cited: 31
An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis
Syed Anas Ansar, Shruti Aggarwal, Swati Arya, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis
Xin Li, Jianbo Zhou, Xue Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114806-114806
Open Access | Times Cited: 18
Metabolites: a converging node of host and microbe to explain meta-organism
Nabarun Chakraborty
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7
Insights into the enigma of oral streptococci in carcinogenesis
Sangeetha Senthil Kumar, Michael D. L. Johnson, Justin E. Wilson
Microbiology and Molecular Biology Reviews (2024) Vol. 88, Iss. 2
Closed Access | Times Cited: 7
Nanodrug-bacteria conjugates-mediated oncogenic collagen depletion enhances immune checkpoint blockade therapy against pancreatic cancer
Zhaoting Li, Fanyi Mo, Kai Guo, et al.
Med (2024) Vol. 5, Iss. 4, pp. 348-367.e7
Closed Access | Times Cited: 7
Engineered Microorganisms for Advancing Tumor Therapy
Jinxuan Jia, Xiaocheng Wang, Xiang Lin, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 7
Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapy
Yanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 867-878
Closed Access | Times Cited: 7
Targeting Tumor Hypoxia with Nanoparticle-Based Therapies: Challenges, Opportunities, and Clinical Implications
Sujit Kumar Debnath, Monalisha Debnath, Arnab Ghosh, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1389-1389
Open Access | Times Cited: 6
Bacteria in cancer therapy: A new generation of weapons
Jun Fan, Yuan Huang, Yi Li, et al.
Cancer Medicine (2022) Vol. 11, Iss. 23, pp. 4457-4468
Open Access | Times Cited: 24
Nanodrug-loaded Bifidobacterium bifidum conjugated with anti-death receptor antibody for tumor-targeted photodynamic and sonodynamic synergistic therapy
Wenhao Li, Zefei Zhang, Jie Liu, et al.
Acta Biomaterialia (2022) Vol. 146, pp. 341-356
Closed Access | Times Cited: 23
Engineering versatile nano-bacteria hybrids for efficient tumor therapy
Weiyi Wang, Weijie Yu, Guangru Li, et al.
Coordination Chemistry Reviews (2023) Vol. 488, pp. 215178-215178
Closed Access | Times Cited: 16
Harnessing bacteria for tumor therapy: Current advances and challenges
Lina Guo, Jinsong Ding, Wenhu Zhou
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 108557-108557
Closed Access | Times Cited: 16
Using bugs as drugs: Administration of bacteria-related microbes to fight cancer
Jiawei Wang, Debadyuti Ghosh, Mohammed Maniruzzaman
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114825-114825
Closed Access | Times Cited: 14
Mechanisms and Potential Clinical Implications of Oral Microbiome in Oral Squamous Cell Carcinoma
Jingyi Wang, Bo Gao
Current Oncology (2023) Vol. 31, Iss. 1, pp. 168-182
Open Access | Times Cited: 14
The application of bacteria-nanomaterial hybrids in antitumor therapy
Susu Xiao, Min Mu, Chenqian Feng, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies
Niloofar Kiaheyrati, Abouzar Babaei, Reza Ranji, et al.
Life Sciences (2024) Vol. 349, pp. 122734-122734
Closed Access | Times Cited: 5
Integration of Salmonella into Combination Cancer Therapy
Besan H. Al-Saafeen, Maria J. Fernandez‐Cabezudo, Basel K. al-Ramadi
Cancers (2021) Vol. 13, Iss. 13, pp. 3228-3228
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top